ExodusPoint Capital Management’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

ExodusPoint Capital Management’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-18,857	Closed	-$454K	–	2368
2023 Q1	$454K	Buy	+18,857	New	+$237K	﹤0.01%	1362
2022 Q2	–	Sell	-12,500	Closed	-$92K	–	2666
2022 Q1	$92K	Sell	12,500 -1,737	-12%	-$10.4K	﹤0.01%	2011
2021 Q4	$80K	Sell	14,237 -14,650	-51%	-$93K	﹤0.01%	1986
2021 Q3	$185K	Sell	28,887 -13,052	-31%	-$83.9K	﹤0.01%	1801
2021 Q2	$354K	Buy	+41,939	New	+$338K	﹤0.01%	1640
2020 Q3	–	Sell	-40,608	Closed	-$573K	–	2362
2020 Q2	$573K	Buy	40,608 +23,197	+133%	+$293K	0.01%	1009
2020 Q1	$160K	Sell	17,411 -103,020	-86%	-$1.33M	0.01%	832
2019 Q4	$1.79M	Buy	120,431 +98,131	+440%	+$874K	0.03%	374
2019 Q3	$152K	Buy	+22,300	New	+$226K	0.01%	1182

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

ExodusPoint Capital Management's PRVB Position: Q2 2023 in Review

ExodusPoint Capital Management sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 18,857 shares — an estimated $454K sold.

ExodusPoint Capital Management first reported a position in PRVB in Q3 2019 and held it in 9 quarters. The position peaked at $1.79M in Q4 2019. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

ExodusPoint Capital Management reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
ExodusPoint Capital Management sold 18,857 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $454K.
ExodusPoint Capital Management first reported a position in Provention Bio, Inc. Common Stock in Q3 2019 and held it in 9 quarters.
ExodusPoint Capital Management's Provention Bio, Inc. Common Stock position peaked at $1.79M in Q4 2019.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on ExodusPoint Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.